Testing conducted at the Zeeh Pharmaceutical Experiment Station to support evaluation of bioequivalence of generic drugs was highlighted at the American Epilepsy Society meeting in Washington, D.C. on Monday December 9, 2013. The recognized program and associated clinical study is a collaboration between researchers at the UW-Madison School of Pharmacy, Drake University College of Pharmacy and Health Sciences, University of Rochester Medical Center, and the University of Cincinnati College of Medicine.
Barry Gidal, professor (CHS) in the Pharmacy Practice Division, at the UW-Madison School of Pharmacy represented the school and Zeeh Station at the press briefing following the conference. View the press release.